Susquehanna International Group, LLP Rockwell Medical, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.67 - $4.4 $10,187 - $26,840	6,100 Added 20.13%	36,400 $144,000
Q2 2024 Aug 15, 2024	SELL	$1.45 - $1.92 $1,305 - $1,728	-900 Reduced 2.88%	30,300 $53,000
Q1 2024 May 07, 2024	SELL	$1.23 - $1.86 $39,729 - $60,078	-32,300 Reduced 50.87%	31,200 $51,000
Q4 2023 Feb 14, 2024	SELL	$1.58 - $2.44 $102,226 - $157,868	-64,700 Reduced 50.47%	63,500 $120,000
Q3 2023 Nov 14, 2023	BUY	$1.83 - $6.19 $43,737 - $147,941	23,900 Added 22.91%	128,200 $266,000
Q2 2023 Aug 11, 2023	BUY	$1.8 - $5.46 $187,740 - $569,478	104,300 New	104,300 $569,000

9.46M

339K

43.3K

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $25.2M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.